Helius Medical Technologies, Inc. Share Price Toronto S.E.
Equities
HSM
US42328V1089
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | +4.21% | -.--% |
Sales 2024 * | 703K 957K 58.42M | Sales 2025 * | 1.31M 1.78M 109M | Capitalization | 4.18M 5.69M 347M |
---|---|---|---|---|---|
Net income 2024 * | -10M -13.61M -831M | Net income 2025 * | -14M -19.06M -1.16B | EV / Sales 2024 * | 5.94 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
-0.26
x | P/E ratio 2025 * |
-0.47
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Helius Medical Technologies, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04/17/04 |
Director of Finance/CFO | 63 | 09/20/09 | |
Chief Tech/Sci/R&D Officer | 57 | 08/21/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Straw
BRD | Director/Board Member | 85 | 18/14/18 |
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04/17/04 |
Blane Walter
CHM | Chairman | 53 | 29/15/29 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.42% | 217B | |
+12.22% | 190B | |
+19.86% | 143B | |
+30.83% | 111B | |
+1.71% | 64.59B | |
+16.07% | 52.36B | |
-0.16% | 48.45B | |
-5.42% | 38.03B | |
+0.45% | 35.6B |
- Stock Market
- Equities
- HSDT Stock
- HSM Stock